About this trial

The goal of this study is to improve the monitoring of fluid retention in cancer patients. The main question it aims to answer is: Can segmental bioelectrical impedance analysis be used to monitor local fluid retention (edema) in cancer patients? We will include:

* Breast cancer patients with fluid and or lymph retention in one or both arms after radiotherapy (outpatients) * Cancer patients with fluid retention in one or both legs after chemotherapy (hospitalized)

Participants will:

* Have measurements taken using bioelectrical impedance * Provide blood samples and 24-hour urine collection * Weight monitorering * Complete diet and fluid registration (inclusive enteral and parenteral) * Have clinical palpatory and measurement assessment of oedema.

Eligibility criteria

Qualifiers

Habile

Must be able to speak and read Danish

Has received/is receiving radiotherapy due to breast cancer within the last 6 months

Is being followed in the Oncology Outpatient Clinic at Aalborg University Hospital

Disqualifiers

Pregnant or breastfeeding women

Amputated limb(s)

Pacemaker or implanted cardioverter-defibrillator due to risk of interference from the electrical signal

Metallic prostheses due to risk of interference with the device signal

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

46 Participants
are grouped into 2 trial groups

Locations

1
Aalborg University Hospital AalborgThe North Denmark Region, Denmark

Sponsors and collaborators

Jens Rikardt Andersen

Lead sponsor

University of Copenhagen

Sponsor institution

Aalborg University Hospital

Collaborator

University of Copenhagen

Collaborator